Since (R)-9b treatment not only activated T cells but also increased CXCL10 expression by cancer cells, we explored collective outcomes using human prostate cancer spheroids that we generated using CRPC-forming C4-2B cells. The gene discussed is CXCL10; the disease is cancer.